| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | DECKERS OUTDOOR CORP CMN | May 9, 2026 | |
| Sell | DEXCOM INC CMN | Apr 24, 2026 | |
| Buy | DEXCOM INC CMN | Apr 24, 2026 | |
| Buy | Quest Diagnostics Incorporat | Mar 30, 2026 | |
| Buy | Quest Diagnostics Incorporat | Mar 27, 2026 | |
| Sell | QUEST DIAGNOSTICS | Feb 10, 2026 | |
| Buy | QUEST DIAGNOSTICS INC CMN | Jan 29, 2026 | |
| Buy | DIAGEO OUTNOSTICORP CMN | Jan 15, 2026 | |
| Buy | DRGCOM, INC. CMN | Dec 1, 2025 | |
| Sell | Quest Diagnostics Incorporat | Nov 3, 2025 |
This page tracks congressional stock trading activity in Quest Diagnostics Incorporated (DGX) in the Healthcare sector. Disclosed Capitol has indexed 144 disclosed congressional trades involving DGX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 144 disclosed congressional trades in Quest Diagnostics Incorporated (DGX) — 68:57 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 9, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Sell | $15,001 - $50,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Mar 30, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Feb 10, 2026 | Michael McCaul | R | Sell | $50,001 - $100,000 |
| Jan 29, 2026 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jan 15, 2026 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Dec 1, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Nov 3, 2025 | Julie Johnson | D | Sale | $1,001 - $15,000 |
Across the 144 disclosed congressional trades in Quest Diagnostics Incorporated (DGX), members of Congress have reported 68 buys and 57 sells. The average 30-day alpha vs. the S&P 500 is 0.44%.
As of August 2026, Quest Diagnostics Incorporated has 3,519 federal contract award records on file from USAspending.gov — most recently -$54K from the Department of Veterans Affairs on 2026-08-03.
| Award date | Agency | Amount |
|---|---|---|
| 2026-08-03 | Department of Veterans Affairs | -$54K |
| 2026-08-03 | Department of the Interior · Departmental Offices | -$106K |
| 2026-06-30 | Department of Veterans Affairs | $67K |
| 2026-06-30 | Department of Veterans Affairs | $1.0M |
| 2026-06-30 | Department of Veterans Affairs | $1.0M |
| 2026-06-29 | Department of Veterans Affairs | $55K |
| 2026-06-29 | Department of Veterans Affairs | $895K |
| 2026-06-26 | Department of Veterans Affairs | -$75K |
| 2026-06-26 | Department of Veterans Affairs | $675K |
| 2026-06-26 | Department of Veterans Affairs | $1.6M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Quest Diagnostics Incorporated reported revenue of $11.04B and net income of $992.0M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $3.04B, net income $320.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.